Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Unusually-High Trading Volume – What’s Next?

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY) saw strong trading volume on Thursday . Approximately 374,341 shares were traded during mid-day trading, an increase of 144% from the previous session’s volume of 153,257 shares.The stock last traded at $13.76 and had previously closed at $13.59.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a research note on Thursday, August 6th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Fresenius SE & Co. presently has an average rating of “Buy”.

Fresenius SE & Co. Price Performance

The firm has a market capitalization of $31.07 billion, a P/E ratio of 17.46 and a beta of 0.61. The business has a 50-day moving average of $12.05 and a 200 day moving average of $12.74. The company has a current ratio of 1.27, a quick ratio of 0.98 and a debt-to-equity ratio of 0.41.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%.The firm had revenue of $6.91 billion during the quarter, compared to the consensus estimate of $6.65 billion. On average, sell-side analysts predict that Fresenius SE & Co. will post 1.08 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.